Trial Profile
Phase I Study of Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Famitinib (Primary) ; Cisplatin
- Indications Nasopharyngeal cancer
- Focus Adverse reactions
- Sponsors Jiangsu Hengrui Medicine Co.
- 16 Apr 2018 Status changed from recruiting to completed.
- 02 Nov 2011 New trial record